Contact
Bone Therapeutics

Unique technology platform

Bone Therapeutics innovative cell therapy Bone Therapeutics is bringing a unique value proposition by developing a range of innovative cell therapy products administrable via a minimally invasive technique.
We aim to improve:

  • Efficacy by developing innovative cell therapy products - both autologous (originating from the patient) and allogeneic (originating from a universal donor) - composed of differentiated bone-forming cells (also called osteoblastic cells).
  • Safety by offering a minimally invasive approach involving implanting the cells with a needle (or trephine) directly at the bone defect site through the skin, replacing the need for invasive surgery.

The company has developed 2 first-in-class products , PREOB® and ALLOB®. The manufacturing process consists of the ex vivo culture of human bone marrow cells in order to generate human osteoblastic cells. All of Bone Therapeutics' products are manufactured to the highest GMP standards and all trials are designed in close consultation with the regulatory authorities. PREOB® and ALLOB® are classified as advanced therapy medicinal products in Europe, which is renowned to have some of the strictest guidelines for the development of cell therapy products.

Watch our video